---
category: trading
circular_id: fc1f8d0e8fb29220
date: '2025-11-14'
description: BSE announces the schedule for the acquisition window (takeover) of J
  B Chemicals & Pharmaceuticals Ltd shares, opening on November 18, 2025, and closing
  on December 1, 2025, with an offer price of Rs. 1,639.18 per share for up to 4.17
  crore equity shares.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={585698A6-1680-4F04-BECE-DEBFF7EFC133}&noticeno=20251114-2&dt=11/14/2025&icount=2&totcount=7&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Major takeover offer involving up to 4.17 crore shares of a listed
  pharmaceutical company with specific trading windows and operational requirements
  for members and custodians
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251114-2&attachedId=
processing:
  attempts: 1
  content_hash: 77d997faaf8c7ca1
  processed_at: '2025-11-14T09:26:04.335311'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-14T03:43:35+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={585698A6-1680-4F04-BECE-DEBFF7EFC133}&noticeno=20251114-2&dt=11/14/2025&icount=2&totcount=7&flag=0
severity: high
source: bse
stocks:
- JBCHEPHARM
tags:
- equity
- live-activities
- otb
- takeover
- trading-schedule
title: Offer to Buy – Acquisition Window (Takeover) for J B Chemicals & Pharmaceuticals
  Ltd - Live Activities Schedule
---

## Summary

BSE has announced the schedule of activities for the Offer to Buy – Acquisition Window (Takeover) for J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM). The offer will be live from Tuesday, November 18, 2025, to Monday, December 1, 2025. The acquirer is offering Rs. 1,639.18 per share for up to 4,17,45,264 equity shares (ISIN: INE572A01036, Scrip Code: 506943).

## Key Points

- Offer Size: Up to 4,17,45,264 equity shares
- Offer Price: Rs. 1,639.18 per share
- Face Value: Rs. 1.00
- Market Lot: 1
- Opening Date: Tuesday, November 18, 2025
- Closing Date: Monday, December 1, 2025
- Trading Members can bid for investors having shares in demat form only
- UCC of investors must be registered with correct PAN Number and Category
- Multiple bidding categories available: FII, FI, MF, IC, OTH, NOH, CO, IND

## Regulatory Changes

No new regulatory changes introduced. This circular provides operational implementation of existing takeover regulations through the OTB (Offer to Buy) module.

## Compliance Requirements

- Trading Members and Custodian Members must note the schedule of activities
- Members must ensure investor UCC is registered/updated with correct PAN Number and Category in Exchange UCC database
- Members can only bid for investors having shares in demat form
- Members must refer to Exchange Notices no. 20150930-1 (September 30, 2015) and 20170203-29 (February 3, 2017) for operational instructions
- Access to iBBS platform via Internet (https://ibbs.bseindia.com/) or Leased Line (https://ibbsll.bseindia.com/)
- Access to RTRMS via Internet (https://rtrms.bseindia.com/) or Leased Line (https://rtrmsll.bseindia.com/)
- Files on Extranet for bid acceptance available after Exchange receives confirmation from Merchant Banker/RTA post-issue closure

## Important Dates

- **Bid Offering Period**: November 18, 2025 to December 1, 2025 (9:15 AM to 3:30 PM)
- **Give-up/Take-up Period**: November 18, 2025 to November 28, 2025 (9:15 AM to 3:30 PM)
- **Give-up (Last Day)**: December 1, 2025 (9:15 AM to 3:30 PM)
- **Take-up (Last Day)**: December 1, 2025 (9:15 AM to 4:00 PM)
- **Notice Date**: November 14, 2025

## Impact Assessment

**Market Impact**: High - This is a significant takeover offer for a listed pharmaceutical company involving over 4.17 crore shares valued at approximately Rs. 6,843 crores at the offer price.

**Operational Impact**: Trading members and custodians need to prepare systems and processes for the two-week OTB window. Investors holding JBCHEPHARM shares have the opportunity to tender their shares at Rs. 1,639.18 per share.

**Investor Impact**: Shareholders of J B Chemicals & Pharmaceuticals Ltd can participate through their trading members during the specified period. Only demat shares are eligible for tendering.

**Contact Support**: Multiple contact points provided for iBBS login issues, password resets, and OTB module queries including Trading Operations (022-22728005) and specific personnel for technical and listing operations support.